Young David

Young David is listed in filings as Pres. Research & Development at Processa Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including purchase activity. Recent filings connect the profile to Processa Pharmaceuticals, Inc. (PCSA). The current snapshot covers public activity from Aug 2, 2024 to Jun 1, 2026. Reported amounts are shown as $4.6K to $2.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.